{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/0641-6253#drug","name":"Regadenoson","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0641-6253"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA215827"},{"@type":"PropertyValue","propertyID":"UNII","value":"7AXV542LZ4"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"9e48b407-1ce3-461d-b48e-de183802de25"}],"activeIngredient":"REGADENOSON ANHYDROUS","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Hikma Pharmaceuticals USA Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA215827","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e48b407-1ce3-461d-b48e-de183802de25","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6253"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-28T02:08:32.860Z"}}